OTC · CEOS
CeCors, Inc.
$0.01+$0.00 (+23.6%)
CeCors, Inc.’s quoted price sits in the upper half of its reported 52-week range, 38.89% below the high.
Loading market information…
OTC · RBII · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Rising Biosciences, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Rising BioSciences, Inc. develops and manufactures topical and oral pharmaceutical products, including medical marijuana products. The company is based in Sheridan, Wyoming.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01+$0.00 (+23.6%)
CeCors, Inc.’s quoted price sits in the upper half of its reported 52-week range, 38.89% below the high.
$0.00$0.00 (0.0%)
Immunotech Laboratories, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Health Advance Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00+$0.00 (+9,900.0%)
AXM Pharma, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Spencer Pharmaceutical Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Nanobac Pharmaceuticals, Incorporated’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Abattis Bioceuticals Corp.’s quoted price sits in the lower half of its reported 52-week range, 70.0% below the high.
$0.00$0.00 (0.0%)
OWC Pharmaceutical Research Corp.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
